Introduction
The goal of this review is to provide an update on the detection, eradication, and prevention of sessile serrated polyps (SSPs). There are two closely related pathology issues that have had a major impact on approaches to understand the importance of these colorectal cancer precursors including the pathologic terminology and histo-molecular identification of the various types of serrated polyps.
Terminology
Within the last two decades, our knowledge of colorectal SSPs has transformed dramatically, and it has led to marked changes in the terminology used to describe the spectrum of serrated polyps. Prior to the 1990s, essentially all serrated polyps were called hyperplastic polyps (HP) and it was thought these lesions had no potential for malignancy. In the 1990s, Longacre and FenogloPreiser et al. coined the term Bserrated adenoma^to describe a class of polyps that Bexhibited the architectural but not the cytologic features of a hyperplastic polyp [ 1] . The identification of this lesion, now called a traditional serrated adenoma (TSA), helped lead to a careful re-evaluation of the entire class of serrated colonic polyps by Torlakovic et al. [2] . It is now believed that specific subsets of serrated polyps account for over 30 % of colorectal cancers (CRCs) [3, 4] .
Suffice it to say that the pathologic definitions and terminology used to describe what we now term SSPs have evolved substantially over the last 20 years; a sampling of terms that have been used includes giant or large hyperplastic polyp, epithelial polyp, mixed hyperplastic/adenomatous polyp, serrated lesion, serrated polyp, and serrated adenoma. Variability in both terminology and definitions has hindered our understanding of this field. In an attempt to standardize the terminology, the World Health Organization (WHO) updated their classification of serrated polyps in 2010 into three categories: (1) hyperplastic polyps, (2) sessile serrated polyps (SSP) with or without cytologic dysplasia (CD), and (3) traditional serrated adenomas [5] . The WHO suggests the terms SSP and sessile serrated adenoma may be used interchangeably; we will use SSP in this review. It is believed that there is a Bserrated^pathway to CRC that has a characteristic histologic and molecular progression from a subset of hyperplastic polyps (HPs) to SSPs to SSPs with cytologic dysplasia (SSP-CD) to serrated CRCs ( Fig. 1 ) and that this pathway is more common in the proximal than in the distal colon [3] . Although TSAs are also thought to have malignant potential, they are much less common than SSPs. This review will focus on the detection, eradication, and prevention of SSPs.
Pathologic Identification
The recognition of SSPs as an important cancer precursor is now well established, and there is a growing acceptance of the WHO classification of serrated polyps. It is generally agreed that SSPs have extension of serrations to lower levels of the crypt rather than being limited to the upper crypt as seen in HPs. In addition, the crypt bases in SSPs can appear dilated and branched and may have a boot, BL,^or anchor shape (Fig. 1) , the so called SSP-like crypts. Despite this general agreement, there remains variability in the identification and classification of serrated polyps among pathologists. Some of the variability is based on differences of opinion regarding diagnostic criteria. For example, the WHO diagnosis of SSPs is based in part on the presence of two or more contiguous SSP-type crypts, whereas a recent review by an expert panel said that the presence of even one unequivocal architecturally distorted, dilated, and/or horizontally branched crypt is enough for an SSP diagnosis [3] . Use of the more lax criteria would be expected to increase the frequency of classifying polyps as SSPs. Indeed, Bettington et al. reported a modest increase in SSP diagnosis using the more lax criteria (14.7 vs. 12.1 % with the WHO criteria) [6] .
It has long been suspected that many polyps that had previously been classified as HPs were probably SSPs. Recent papers have helped quantify the magnitude of this misclassification. In 2010, Kim et al. re-evaluated the pathology of 49 serrated polyps larger than 1 cm that had previously been reported as HPs and re-classified almost 20 % as SSPs [7] . More recently, Tinmouth et al. found that almost 30 % of HPs larger than 5 mm removed between 2003 and 2008 were reclassified to SSPs upon review using current WHO criteria [8] . Similarly, Singh and colleagues reviewed over 4000 pathology reports from 2009 by 25 different pathologists, of which 20 % were initially characterized as serrated colon polyps. Seventeen percent of proximal HPs and 20 % of serrated lesions over 5 mm were reclassified as SSPs [9] . Thus, it is likely that a significant number of SSPs are still misclassified in daily practice.
The high misclassification rate of proximal and large serrated polyps has led some experts to recommend that any serrated polyp (including hyperplastic polyps) larger than 1 cm in size be considered an SSP, and this recommendation has directly impacted surveillance guidelines for serrated polyps as described below [3, 10] . Histologic misclassification has also confounded both clinical and molecular studies of serrated polyps. As a result, many retrospective studies that are not able to re-review the pathology have looked at proximal serrated polyps as a group as a surrogate for SSPs.
Molecular Identification
The serrated pathway to CRC appears to have characteristic molecular as well as histologic features (Fig. 1) . Whereas the conventional adenoma-carcinoma sequence involves the sequential acquisition of mutations (i.e., APC/KRAS/P53) that ultimately leads to chromosomal instability and tumor development [11] , the serrated pathway appears to be driven by both genetic and epigenetic events [3, 11, 12] . Mutations in the BRAF gene and abnormal methylation of DNA termed the CpG island methylator phenotype (CIMP) are frequently found in HPs and SSPs and are thought to be early events in the serrated pathway. Later in the serrated pathway, CIMP often leads to hypermethylation of the DNA mismatch repair gene MLH1, leading to its epigenetic silencing. This, in turn, causes defective mismatch repair and microsatellite instability (MSI). It is not clear how long it takes to progress through the early steps of the serrated pathway, although it has been estimated that it takes about 8 years on average to progress from an HP to an SSP, but the later events are thought to occur more rapidly [13] . Loss of MLH1 is typically seen in the dysplastic foci of SSP-CD, and the resultant MSI is thought to lead to rapid progression to CRC in a manner analogous to the accelerated adenoma-carcinoma sequence known to occur in Lynch syndrome [3, 14] . SSP-CDs are thought to be the immediate precursors of sporadic MSI-H CRCs. Past studies of the molecular features of SSPs have been hindered by the histologic misclassification described above, but it is possible that molecular and pathologic criteria can be used together to more reliably identify these critical lesions.
Elucidation of the clinical and molecular features of SSPs and serrated adenocarcinomas (BRAF mutant, CIMP-H, MSI-H) has demonstrated that this pathway contributes disproportionately to the development of CRCs that occur in screened individuals before their next scheduled screening test; these CRCs have been called interval CRCs. Multiple studies have shown decreased benefit of screening colonoscopy for prevention of CRCs in the proximal compared to the distal colon [15, 16] . These proximal interval CRCs tend to have CIMP and BRAF mutations more commonly than non-interval CRCs, suggesting that the serrated pathway is a preferential contributor to interval CRCs [17, 18] . This differential risk could be due to a more rapid progression of the serrated pathway to CRC, but it seems more likely that the failure to detect and/or completely remove SSPs are the major contributors. It has been estimated that 50 to 75 % of interval CRCs are the result of missed or incompletely resected lesions and that less than 30 % are due to rapidly progressing lesions [19] [20] [21] .
Detection
SSPs are difficult to detect. They are more common in the right colon where the prep is often poor; they tend to be flatter with paler mucosa than conventional adenomas, and they are often covered with a mucus cap. Given their endoscopic subtlety and their definite potential for transformation to malignancy, these lesions have proven to be a challenging dilemma to practicing gastroenterologists.
Prevalence of Serrated Polyps
Older studies have suggested that the prevalence of SSPs ranged from 0.6 to 5.3 %; however many of these investigations did not use the current WHO standard terminology for the histological classification of serrated polyps [5, [22] [23] [24] [25] [26] . The true prevalence of SSPs is dependent on both the detection rate and the correct pathologic classification of these lesions, and there is evidence of considerable variability of both these factors.
Kahi et al. reported results of a retrospective review of 6681 screening colonoscopies performed by 15 endoscopists at two US academic endoscopy units. A total of 11,049 polyps were detected of which 51 % were adenomas, 36 % were serrated polyps, and 11 % (N=1238) were proximal serrated polyps. There was a significant (pG0.0001) variability in the rates of detection of any proximal serrated polyp with rates ranging from 1 to 18 % which is substantially greater than the 2.8-fold range in variability of conventional adenoma detection rates (ADRs) among the same endoscopists [27] . De Wijkerslooth et al. reported similar results in a prospective study of 1354 patients undergoing screening colonoscopy at two academic centers in the Netherlands. A total of 1635 polyps were detected of which 42 % were serrated and 13 % of those were proximal to the splenic flexure. The proximal serrated polyp detection rate differed significantly among endoscopists ranging from 6 to 22 % [28] .
The histologic classification of SSPs also varies significantly among pathology laboratories. For example, Payne and colleagues reviewed the range of reported prevalence of significant proximal serrated polyps found at screening colonoscopy in 7215 patients at 32 endoscopy centers. Each center individually interpreted the pathology, with significant serrated lesions in the proximal colon defined as HPs greater than 10 mm, SSPs, and TSAs. The detection rate of significant proximal serrated lesions among the 32 centers varied greatly ranging from 0 to 9.8 %, and the authors noted that some pathologists never identified proximal serrated lesions as SSPs [29] .
One recent study tried to control for both variability in detection and pathologic classification in order to estimate a more precise prevalence of SSPs. The authors reported the results of 1910 screening colonoscopies in average-risk, asymptomatic patients performed by a single, high adenoma detecting endoscopist with histologic interpretation by a single, experienced GI pathologist. All serrated rectosigmoid polyps 95 mm and serrated polyps proximal to the sigmoid colon were included. One or more serrated polyps were found in 389 of 1910 patients (20 %). The prevalence of SSPs was 7.4 % and that of SSP-CDs was 0.6 % [30] .
Both Kahi et al. [27] and Payne et al. [29] have reported that the proximal serrated polyp detection rate was significantly correlated with the adenoma detection rate (ADR) of an individual endoscopist. Some of the causes of the variability in SSP detection seem to be similar to those reported for the ADR variability. For example, longer withdrawal times, which are known to be associated with higher ADRs, have also been reported to be significantly associated with higher proximal serrated polyp detection rates [28, 31] . In contrast, poor bowel prep is known to impair detection of conventional adenomas, but, surprisingly, it has not been consistently shown to impair SSP detection [28, 32] . A recent cross-sectional study, for example, compared the impact of optimal versus poor bowel preparation on polyp detection rates in a registry of over 13,000 patients using a standardized bowel preparation scale. The authors found that the proximal ADR rates were statistically lower in the poor preparation category than in adequately prepared colons; however the serrated polyp detection rate (SPDR), while numerically lower, was not statistically so (odds ratio 0.45, confidence interval (CI) 0.24-0.84 and odds ratio 0.75, CI 0.31-1.80, respectively) [32] . Similar results were reported in a prior study that reviewed 1300 patients undergoing screening colonoscopy [28] . Postulated explanations for these unexpected results include residual stool being attached to mucous caps highlighting SSPs, additional washing of the colon leading to greater attention to the mucosa, or the fact that SSPs are less common than conventional adenomas, and the studies were not adequately powered to show a difference in SPDR as a function of prep quality. Other factors such as patient age and sex have not been shown to significantly influence the SPDR.
Improving Detection of SSPs-Endoscopic Morphology
Substantial recent efforts have been made to improve the overall endoscopic detection of SSPs and to define their specific features. In 2011, Tadepalli and colleagues retrospectively analyzed video clips of 158 SSPs detected during routine high-resolution colonoscopy. They characterized seven morphologic descriptors of SSPs that were consistently found in SSPs. The most common features that first captured endoscopists' attention to the lesion were termed Bsentinel signs^and included a mucous cap (25 %), alteration of the contour of a mucosal fold (25 %), a rim of debris or bubbles (21.7 %), and a dome-shaped protuberance (20.3 %). Although not the initial sign, an interruption of the underlying mucosal vascular pattern was found in 32 % of the SSPs. Over 90 % of the SSPs were minimally elevated (less than 2.5 mm above the adjacent flat mucosa) and had Paris Classification Type 0-II morphology [33] . Another review by an expert panel identified similar sentinel signs and described less common morphologic features such as a subtle nodularity seen in 9 % of SSPs [3] .
Chromoendoscopy (CE) and Image-Enhanced Endoscopy
Chromoendoscopy and image-enhanced endoscopy, particularly narrow band imaging (NBI) and autofluorescence imaging (AFI), are well-established tools for distinguishing adenomas from hyperplastic polyps but less useful for improving ADRs [34] . A meta-analysis in 2012 found that compared to white light, NBI did not improve the ADRs [35] . In addition, a recent comprehensive meta-analysis of all of these techniques found that none of the imageenhancing approaches improved ADRs except for CE [36] .
SSPs also have characteristic CE and NBI features. Kashida et al. reported that SSPs have a Bstar-like^pit pattern with CE that distinguished them from TSAs and adenomas but was similar to the pattern in typical HPs [37] . Using NBI, the mucus caps over SSPs appear red, the underlying mucosa can appear almost white, and large dark spots may be seen inside the crypts. NBI imaging has been used to distinguish serrated polyps from adenomas, and NBI characteristics of SSPs have also been described in this context. In a recent study, a cloud-like, bumpy, softlooking nodular surface with indistinct borders, irregular shape, and dark spots inside the crypts were found to be endoscopic predictors of SSP histology. If all of these features were present (compared to none), they showed high sensitivity (89 %), specificity (96 %), and accuracy (93 %) for predicting SSP histology [38] .
It is not known if the use of either CE or image-enhanced endoscopy can increase the detection rate of sporadic SSPs, but NBI has been reported to increase polyp detection rates in patients with serrated polyposis syndrome (SPS). Boparai et al. compared the miss rate of serrated polyps in patients with SPS using high-resolution endoscopy (HRE) followed by NBI and vice versa. The overall polyp miss rate was 36 % for HRE and 10 % for NBI (odds ratio (OR) 0.21, 0.09-0.45) [39] . Based in part on this study, the European Society of Gastrointestinal Endoscopy recommends routine use of pan-colonic NBI, or CE, in patients with known or suspected serrated polyposis syndrome [40] .
Other Detection Modalities

Proximal Retroflexion
Retroflexion of the colonoscope in the proximal colon has been performed in hopes of improving detection of inconspicuous polyps in this region. A small RCT and an observational descriptive cohort study have suggested that proximal retroflexion is no better in detecting additional polyps compared to a forward view Bsecond look^of the proximal colon during routine colonoscopy [41, 42] . However, proximal retroflexion appears to be easily performed with minimal risk and may have a role in assessing and removing larger flat polyps [43] .
Water Immersion
Recently, a retrospective consecutive group observational study compared water immersion with cap-assisted colonoscopy (WCC) to white light colonoscopy and found that WCC was associated with a higher ADR (75.0 vs. 59.4 %, P=.02), proximal colon ADR (61.0 vs. 47.5 %, P=.07), and proximal colon serrated polyp detection rate (24.0 vs. 9.9 %, P=.009) [44] . This result awaits confirmation.
Endocytoscopy
A newer technology, known as endocytoscopy, has the potential to better delineate colonic lesion characteristics. Endocystoscopy is an ultra-high magnification technique that enables surface morphology to be assessed in real time, with magnifications in excess of 450×. This technology requires staining of the mucosa with crystal violet or methylene blue and uses a high-power fixed-focus objective lens that can either be incorporated into the endoscope or comes in a probe-based system [45] . Using this technology, stellar and papillary pit patterns with open pits (Kudo Type II-O) have been found to be highly specific (97 %) for SSPs with a sensitivity of 66 % [46, 47] . Kutsukawa and colleagues reported similar results in a retrospective review of endoscopic features of 58 pathologically diagnosed serrated polyps. Lumen and nuclei patterns were recorded, and what was noted was Kudo Type II patterns were significant characteristics of hyperplastic polyps, while oval lumens (Kudo Type II-O) were significant characteristics of SSPs [48] . While intriguing, endocytoscopy is currently a research tool and is unavailable in many western countries. Even if this technology is shown to improve the differentiation of SSP from other types of polyps, it is uncertain if it would be useful in increasing SSP detection rates.
Eradication
As noted earlier, SSPs contribute disproportionately to interval CRCs, and incomplete resection of colonic polyps on prior colonoscopy could account for 20-30 % of interval cancers [20, 21, 49, 50] Incomplete polyp resection occurs more commonly for SSPs than other types of colonic polyps. In the 2013 CARE study, Pohl and colleagues studied 269 patients who had a total of 346 resected non-pedunculated neoplastic polyps that ranged from 5 to 20 mm in size [19] . After the endoscopist thought the polyp had been completely eradicated, cold biopsies were obtained from the resection margin to determine if the resection was complete. Of the resected polyps, 59.3 % were right sided and 10 % were SSPs. Overall, 10 % of the polyps were incompletely resected and SSPs were more likely to be incompletely resected than adenomas (31 vs. 7 %, relative risk (RR) 3.7). Strikingly, 48 % of SSPs greater than 10 mm were incompletely resected. The incomplete resection rate ranged from 6.5 to 22.7 % among five endoscopists [19] . Thus, in addition to a high ADR, skilled endoscopic technique to ensure complete polyp eradication is necessary to confer the ultimate benefit of polypectomy, and this is particularly important for SSPs.
Polypectomy Techniques
All but the tiniest rectosigmoid, hyperplastic-appearing polyps should be completely endoscopically removed whenever feasible. As SSPs tend to be flat, large, and located in the proximal colon, concern may be raised over the safety of their removal. Currently, the evidence suggests that removal of SSPs can be performed safely and does not lead to a higher rate of perforation than adenomas with similar characteristics [51, 52] . It has been recommended that all sessile polyps larger than 3 mm be removed with a cold or hot snare with a rim of normal surrounding tissue rather than with biopsy forceps to allow complete removal [3] . The edges of SSPs are often indistinct, and narrow band imaging or chromoendoscopy can assist in ensuring their perimeter for complete removal. Submucosal injection of larger SSPs with a dye-containing liquid (i.e., methylene blue) can provide elevation of the lesion and nicely define polyp edges to improve the chance of obtaining adequate margins. The edges of the polypectomy site should be carefully assessed, and any residual polyp tissue should be completely removed; argon plasma coagulation or cautery with the snare tip is particularly useful for this purpose. If an SSP does not lift when performing injection techniques, it may be due to scarring from previous attempts at resection, or it may be an indication of invasive cancer and sampling may be prudent [53] . The decision of whether to undertake endoscopic resection of SSPs will ultimately depend on lesion's characteristics and endoscopist's skill level, but almost all lesions can safely be removed endoscopically with surgical resection rarely being required.
In situations where submucosal injection is not feasible, underwater endoscopic mucosal resection (UEMR) without injection, in the hands of experts, has been proposed as an alternative approach. One variant of this technique involves cap-assisted endoscopy with full water immersion for the entire procedure and piecemeal resection with a hot 15 mm Bduck bill^snare. A pilot study of this technique reported the resection of 62 large (mean size 3.5 cm) sessile polyps (18 % were serrated adenomas) in 60 patients. At a mean followup of 20 weeks, none of 54 patients had evidence of incomplete resection [54] . Wang et al. recently reported similar UEMR results with complete resection of 42 of the 43 lesions in a consecutive patient population referred for resection of large colorectal neoplasms (7 % SSPs) [55] .
Prevention
The usual approach to primary prevention of CRC or neoplastic colorectal polyps is to alter modifiable risk factors as well as utilize effective nutritional or chemopreventive agents. While tobacco use is associated with the presence of SSPs, there is relatively little else known about the primary prevention of SSPs. The focus of secondary prevention is on high-quality surveillance colonoscopy, complete eradication of SSPs as described above, and finally on improving our recognition and understanding of SPS.
Risk Factors
For adenomas and CRC, many non-modifiable risk factors have been identified including increasing age, male gender, African American race, country of origin, a history of inflammatory bowel disease, and a personal or family history of colonic neoplasia. In addition, modifiable risk factors for these lesions include obesity, lack of physical activity, alcohol and/or tobacco use, and diets high in red meat and low in high-fiber foods [56] [57] [58] [59] . Distal serrated polyps (mostly HPs) are also associated with tobacco use, lack of physical activity, and low folate intake [60] [61] [62] [63] . Unlike adenomas, however, SSPs have not been associated with increasing age or male gender, and other risk factors such as obesity, family history of CRC, or intake of alcohol, fiber, or calcium have not consistently been associated with either HPs or SSPs [61, 64, 65] . Even the association of SSPs with tobacco use is not totally consistent. Wallace et al. found an association with tobacco use for left-sided advanced serrated polyps (including SSPs) but not for those in the right side [64] . However, smoking has been strongly associated with MSI-H CRCs [66] which arise from SSPs.
Chemoprevention Aspirin Use
A systematic review by Algra found that regular aspirin use was associated with about a 20-40 % reduction in the risk of both CRC and colonic adenomas [67] . Wallace et al. also reported that aspirin was associated with a reduced risk of both left-and right-sided serrated polyps (RR 0.56, 95 % CI 0.34-0.91) [64] . Aspirin appears to prevent MSI-H CRCs in Lynch syndrome, but there is relatively little data about its effect on sporadic serrated CRCs [68] . In an older study, Chia et al. found that long-term NSAID users were less likely to develop microsatellite stable CRCs (OR 0.6, 95 % CI 0.4-0.8) whereas there was no similar relationship with MSI-H CRCs (OR 0.9, 95 % CI 0.5-1.4) [66] .
The chemopreventive action of aspirin is thought to stem from its inhibition of COX-2 and subsequent decreased prostaglandin production. COX-2 has been found to be upregulated in CRCs, but Kawasaki et al. reported that SSPs rarely show overexpression of COX-2, thus, disputing a biologic rationale for NSAID chemoprevention for these polyps [69] . Similarly, Nishihara reported that regular aspirin use was not associated with a decreased risk of BRAF-mutated CRCs (recall that BRAF mutations are a marker of the serrated pathway) [70] . PIK3 mutation has been identified as a possible marker for the positive response to regular aspirin use as adjuvant therapy for CRC [71] . PIK3 mutations are found in 10-20 % of CRC but have been associated mainly with KRAS mutations and less consistently with markers of the serrated pathway such as CIMP, MSI, and BRAF mutations [72, 73] . Taken together, it is not certain whether aspirin will be effective in preventing CRCs derived from the serrated pathway.
Although the study by Wallace et al. highlights the association between regular aspirin use and reduced risk of right-sided serrated polyps, the magnitude of the chemopreventive effect of aspirin is unknown and the data for serrated CRC prevention is weak [64] . Therefore, the regular use of aspirin for primary prevention of SSPs cannot currently be recommended.
Given the difficulty identifying patients at increased risk of SSPs, a risk score for identifying high-risk SSPs was developed by Bouwens et al. using the predictive factors of age 950, history of SSP, tobacco use, and lack of aspirin use [74] . This score has not been studied well enough to recommend its use, but it can serve as a reminder to endoscopists about the relevant risk factors for SSPs.
Secondary Prevention Current Guidelines for Surveillance
The natural history of serrated polyps is not well understood, and controlled trials of screening and surveillance have not been done. As a result, surveillance guidelines are largely based on observational studies and expert opinion [3, 10, 75] . The US Multi-Society Task Force on Colorectal Cancer (MSTF) guidelines (Table 1 ) recommend a screening interval of 10 years for patients with only diminutive (G5 mm) distal HPs. Surveillance intervals for patients with SSPs are based upon polyp characteristics including size, number, and histology in a manner analogous to that for adenomas (colonoscopy surveillance at 5 years for 1-2 small SSPs and 3 years any large SSP) and treating SSP-CD like advanced adenomas (colonoscopic surveillance in 3 years or less).
Guidelines from the National Comprehensive Cancer Network (NCCN) and those proposed by Rex et al. are broadly similar to those in Table 1 [3, 75] . But, Rex et al. provide more detailed surveillance recommendations including surveillance colonoscopy at 10 years for patients with 1--3 diminutive (G5 mm) proximal HPs, 5 years for any non-diminutive proximal HP, or ≥4 diminutive proximal HPs and 1-3 years for two or more large (≥1 cm) SSPs in any location as well as for any SSP-CD [3] . These authors also emphasize the point that high-quality colonoscopy is central to any surveillance program. Both the MSTF guidelines and those proposed by Rex et al. recommend that large HPs be considered the same as SSPs [3, 10] . The definitive follow-up for SSPs should also reflect the completeness of the polyp removal. If a large SSP is taken out piecemeal, a repeat exam in 3-6 months is appropriate given the risk for incomplete resection [3, 75] .
Although SSPs and conventional adenomas have distinct molecular pathways, the presence of both types of polyps in one patient appears to identify a higher risk population. In a retrospective cross-sectional study, for example, Vu et al. showed that patients with both types of lesions tended to have large SSPs as well as more numerous and more advanced adenomas than patients with either type of polyp alone. Thus, it seems reasonable to combine SSPs with adenomas when making surveillance recommendation (i.e., one SSP and two small tubular adenomas would warrant a 3-year follow-up) [76] .
Serrated Polyposis Syndrome (SPS)
SPS is characterized by the presence of multiple serrated polyps (SSPs, HPs, TSAs) throughout the colon. It is not yet known if SPS is hereditary. There is no mutation known to cause SPS, and therefore the diagnosis is based on clinical criteria. The WHO criteria for SPS include a cumulative lifetime total of as follows: (1) ≥5 serrated polyps proximal to sigmoid colon with ≥2 polyps 91 cm or (2) ≥20 serrated polyps of any size distributed throughout the colon (not limited to the rectosigmoid) or (3) ≥1 serrated polyp proximal to the sigmoid colon in a patient with a first-degree relative with SPS [77] . The prevalence of SPS is unclear with estimates ranging from 1/100,000 to as high as 1/3000; undoubtedly, SPS is seriously underdiagnosed and the prevalence could be even higher than these estimates [78] . The risk of CRC in SPS is not well defined; case series have reported risks as high as 30-50 %, and Boparai reported a CRC incidence of 7 % at 5 years in patients undergoing regular surveillance [79] [80] [81] . It is recommended that all polyps 95 mm in size be removed in patients with SPS. Once the polyps are removed, surveillance every 1-3 years is recommended (Table 2) [3, 10, 75] . First-degree relatives of SPS patients have also been reported to have an elevated risk of CRC (5.4, 95 % CI 3.7-7.8), and they are advised to undergo colonoscopy at age 40 or 10 years prior to CRC or SPS development in the affected relative, whichever is earlier (Table 2 ) [82] .
Summary/Concluding Remarks
The SSP is a specific type (the evil twin) of colonic polyp that is central to the serrated pathway to CRC. Our understanding of this pathway continues to evolve rapidly, but it has already transformed thinking of colorectal carcinogenesis from the adenoma-carcinoma sequence to include the serrated polypcarcinoma pathway with the SSP as the precursor of up to 30 % of all CRCs. Molecular and genetic similarities link SSPs to MSI-H sporadic CRCs, and this knowledge was a critical component of the recognition of the serrated cancer pathway, clearly exemplifying the important contribution of molecular pathology to clinical care. There are important issues that need to be addressed in this field including residual variability in pathologic terminology for the classes of serrated polyps, the high interobserver variation in the pathologic identification of SSP, the high endoscopic miss rate and incomplete resection rate of SSP, and the underdiagnosis of SPS, among others. Recognition of these problems has been the first step in developing solutions including increased pathologist awareness regarding the importance of these polyps, ensuring adequate proximal colon cleansing with split bowel preparations, and endoscopic techniques to improve visualization and lesion resection. High-quality colonoscopy and complete polypectomy are the most effective ways to prevent CRCs arising from the serrated pathway, and guidelines have now been developed that aid in the management of patients with serrated polyps. There is certainly more knowledge to gain in this area, but progress is clearly being made. 
